Skip to main content

Table 2 Comparison of mean Serum creatinine between the 2 arms from baseline to day 28

From: Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin

Day Mean SCr
Mean ± SD (mg/dl)
P-Value
Electrolyte Supplementation Arm (n) Non-electrolyte Arm (n)
Day 0 (baseline) 0.9008 ± 0.1430 (49) 0.8948 ± 0.1960 (50) 0.8621
Day 7 0.9177 ± 0.1941 (47) 1.075 ± 0.3730 (44) 0.0126
Day 14 0.9902 ± 0.1876 (44) 1.264 ± 0.5493 (42) 0.0025
Day 21 0.8693 ± 0.2385 (42) 1.315 ± 0.6347 (41) < 0.0001
Day 28 1.052 ± 0.3602 (26) 1.060 ± 0.2918 (25) 0.9305